Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esab (ESAB) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Esab (ESAB) over the last 5 years, with Q4 2025 value amounting to $669.1 million.

  • Esab's Total Current Liabilities rose 502.35% to $669.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $669.1 million, marking a year-over-year increase of 502.35%. This contributed to the annual value of $632.1 million for FY2024, which is 193.02% up from last year.
  • Esab's Total Current Liabilities amounted to $669.1 million in Q4 2025, which was up 502.35% from $686.5 million recorded in Q3 2025.
  • Esab's Total Current Liabilities' 5-year high stood at $686.5 million during Q3 2025, with a 5-year trough of $596.6 million in Q4 2021.
  • Its 5-year average for Total Current Liabilities is $635.1 million, with a median of $631.7 million in 2024.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 369.27% in 2023, then soared by 644.67% in 2025.
  • Quarter analysis of 5 years shows Esab's Total Current Liabilities stood at $596.6 million in 2021, then rose by 0.84% to $601.6 million in 2022, then rose by 3.08% to $620.1 million in 2023, then grew by 1.93% to $632.1 million in 2024, then increased by 5.86% to $669.1 million in 2025.
  • Its last three reported values are $669.1 million in Q4 2025, $686.5 million for Q3 2025, and $672.0 million during Q2 2025.